In the News
Metformin use associated with cognitive impairment
Metformin is associated with cognitive impairment in people with type 2 diabetes, but the effect may be mitigated by vitamin B12 and calcium supplements, a new study found.
Linagliptin may be effective for elderly patients, study finds
Linagliptin appeared efficacious in patients age 70 years or older with type 2 diabetes who didn't achieve glycemic control from other regimens, and it had a safety profile similar to placebo, reported an industry-funded trial.
Healthy diet may decrease CKD risk in type 2 diabetes
Patients with type 2 diabetes who eat a healthy diet may have a lower risk of developing chronic kidney disease (CKD), according to a recent study.
MKSAP Quiz: Elevated hemoglobin A1c
This month's quiz asks readers to evaluate a 48-year-old woman with type 2 diabetes after laboratory study results show a hemoglobin A1c value of 8.5%.
Oral fluoroquinolones associated with increased dysglycemia risk in diabetics
Diabetic patients taking oral fluoroquinolones could have a higher risk for severe dysglycemia, according to a recent study.
New score predicts dementia risk for type 2 diabetics
A dementia risk score specific to patients with type 2 diabetes was derived and validated by a recent study.
Diabetes debates defy easy resolution
Learn what speakers at the American Diabetes Association's 73rd Scientific Sessions said about use of sulfonylureas, diabetes and osteoporosis, and concentrated insulin in the September ACP Internist.
Meta-analysis assesses sodium-glucose cotransporter 2 (SGLT2) inhibitors
Sodium-glucose cotransporter 2 inhibitors appear to be an effective option to lower blood sugars in type 2 diabetes, but there is insufficient evidence on their safety and long-term effects, a recent meta-analysis found.
Review: In patients with chronic diabetic foot ulcers, hyperbaric oxygen reduces major amputations
According to a review of treating chronic diabetic foot ulcers with hyperbaric oxygen (HBO), HBO resulted in more healed ulcers and fewer major amputations, but no difference in minor amputations.
Ask many questions
The questions you ask during visits with patients with type 2 diabetes, especially those who have been recently diagnosed, will inform your treatment plan.
Spotlight on cardiovascular risk
Several recent studies addressed the effects of diabetes and diabetes treatments on cardiovascular risk.